All Articles

Vyome is set to present promising Phase 2 data for VT-1953, a first-in-class treatment for a debilitating cancer complication with no approved drugs.

In a pivotal move from R&D to commercial scale, Zivo Bioscience partners with industry leader Cyanotech to meet global demand for its unique algal biomass.

The partnership grants 62,000+ financial advisors access to Harbor Group International's specialized, income-oriented multifamily private credit strategies.

CanTex Capital's landmark sale of a 1.3M sq ft portfolio to Partners Group highlights booming demand for DFW's strategic shallow bay industrial assets.

New data shows companies working with CEO Coaching International are seeing revenue and profit growth that nearly doubles and triples U.S. market averages.

Boston's Bio-IT World conference shifts from AI theory to execution, showcasing how the life sciences industry is now deploying AI to accelerate new therapies.

An expanded partnership aims to move businesses from AI experimentation to autonomous operations, tackling the critical 'last-mile problem' of value realization.

With a multi-billion dollar track record of IPOs and acquisitions, the veteran CEO's appointment signals Frazier's focus on navigating complex markets.

This April, families nationwide are walking to fund a new strategy for Lennox-Gastaut Syndrome, aiming to slash diagnosis times and find real cures.

With new CEO Stan Lequin and private equity backing, Fidus Systems is pivoting to infuse AI into embedded design, signaling a new era of growth and M&A.

Metazoa's new Intelligent Assistant for Salesforce goes beyond diagnostics, promising to actively help admins and developers remediate org complexity.

Energy Capital Partners is buying back nuclear services leader EnergySolutions, signaling Wall Street's growing confidence in nuclear's role in the energy future.

Hundreds of thousands of U.S.-born children live in exile after parental deportation. A new initiative aims to restore their rights and build a path home.

Amid financial headwinds, radiation therapy firm Accuray appoints a proven sales leader to spearhead a critical commercial transformation.

With its public debut on the horizon, S&P Global Mobility hires a seasoned expert in corporate separations to lead its financial structuring.

Apnimed has secured up to $150M to launch AD109, a potential first-ever pill for sleep apnea, promising relief for millions tired of CPAP machines.

At AAN 2026, SK Life Science will present new cenobamate data and survey findings that expose a critical communication gap in epilepsy care.

Digital health leader Bunny Ellerin joins Aegis Ventures as Chief Ecosystem Officer, a strategic move to fuel AI-native innovation through network power.

Two family-founded Glendora dental practices, now led by the next generation, partner with a national group to preserve their legacy and expand care.

A long-acting ketamine injection shows promise in treating severe depression without the harsh side effects and monitoring, potentially expanding access for millions.